Edited by Stephen Scypinski, Ph.D. - Vice President, Analytical Development and Quality Control, Eyetech Pharmaceuticals.

Dr. Scypinski received his B.S., M.S. and Ph.D. degrees in Chemistry from Seton Hall University. Involved in analytical and pharmaceutical chemistry for over 22 years, Dr. Scypinski has held positions at Exxon Research and Engineering Co., Varian Instrument Group, Berlex Laboratories and Hoffmann-La Roche. His most recent position prior to joining Eyetech was Director of the Analytical Chemistry Research & Development Department at The R.W. Johnson Pharmaceutical Research Institute. An accomplished scientist as well as manager, Dr. Scypinski serves on the editorial review board for several analytical chemistry journals and is co-editor of the textbook “Handbook of Pharmaceutical Analysis.” Well-versed in both the scientific and regulatory facets of pharmaceutical analysis, Dr. Scypinski has experience both in US and worldwide regulatory filings as well as the pre-approval inspection process.